Quick Answer
Silo Pharma, Inc. reported Net Income of -$4.23 million for fiscal year 2025.
Silo Pharma, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$4.23M | +3.8% |
| 2024 | -$4.39M | -18.7% |
| 2023 | -$3.70M | +5.3% |
| 2022 | -$3.91M | -200.1% |
| 2021 | $3.90M | +228.5% |
| 2020 | -$3.04M | -199.8% |
| 2019 | -$1.01M | -4.5% |
| 2018 | -$969.5K | -371.9% |
| 2017 | $356.5K | +1003.9% |
| 2012 | -$39.4K | +20.8% |
| 2011 | -$49.8K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.11M | -19.6% | +7.8% |
| June 30, 2025 | -$1.20M | -29.2% | -16.8% |
| March 31, 2025 | -$1.03M | -28.7% | -11.0% |
| September 30, 2024 | -$928.8K | -40.7% | +0.3% |
| June 30, 2024 | -$931.8K | +8.0% | -16.2% |
| March 31, 2024 | -$801.7K | +11.6% | -21.4% |
| September 30, 2023 | -$660.2K | +32.9% | +34.8% |
| June 30, 2023 | -$1.01M | -53.8% | -11.8% |
- Silo Pharma, Inc. showed an increase of +3.8% in Net Income compared to the prior fiscal year.
- Over the 2011–2025 period, Silo Pharma, Inc.’s net income has declined by 8388.8% (from -$49.8 thousand to -$4.23 million).
- The most recent figure is from Silo Pharma, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: